JP2003501038A - 蛋白質キナーゼ - Google Patents
蛋白質キナーゼInfo
- Publication number
- JP2003501038A JP2003501038A JP2001500781A JP2001500781A JP2003501038A JP 2003501038 A JP2003501038 A JP 2003501038A JP 2001500781 A JP2001500781 A JP 2001500781A JP 2001500781 A JP2001500781 A JP 2001500781A JP 2003501038 A JP2003501038 A JP 2003501038A
- Authority
- JP
- Japan
- Prior art keywords
- sequence number
- seq
- sequence
- polypeptide
- kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13650399P | 1999-05-28 | 1999-05-28 | |
| US60/136,503 | 1999-05-28 | ||
| PCT/US2000/014842 WO2000073469A2 (en) | 1999-05-28 | 2000-05-26 | Protein kinases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003501038A true JP2003501038A (ja) | 2003-01-14 |
| JP2003501038A5 JP2003501038A5 (enExample) | 2007-06-14 |
Family
ID=22473127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001500781A Withdrawn JP2003501038A (ja) | 1999-05-28 | 2000-05-26 | 蛋白質キナーゼ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060234344A1 (enExample) |
| EP (1) | EP1180151A2 (enExample) |
| JP (1) | JP2003501038A (enExample) |
| AU (1) | AU5173400A (enExample) |
| CA (1) | CA2383244A1 (enExample) |
| WO (1) | WO2000073469A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008522596A (ja) * | 2004-12-10 | 2008-07-03 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 血清/糖質コルチコイド調節キナーゼの使用 |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020028772A1 (en) * | 1997-05-21 | 2002-03-07 | Children's Med. Corporation, | Modulators of activity of G-protein-coupled receptor kinases |
| US7037891B2 (en) | 1997-05-21 | 2006-05-02 | Children's Medical Center Corporation | Methods of modulating G-protein-coupled receptor kinase-associated signal transduction |
| US6605456B1 (en) | 1998-08-04 | 2003-08-12 | Immunex Corporation | Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases |
| JP2002524048A (ja) | 1998-08-04 | 2002-08-06 | イミュネックス・コーポレーション | キナーゼ機能を有するポリペプチドをコードするヒトcDNA |
| US20030028004A1 (en) * | 2000-12-22 | 2003-02-06 | Millennium Pharmaceuticals, Inc. | 68730 and 69112, protein kinase molecules and uses therefor |
| US20020077312A1 (en) * | 2000-09-25 | 2002-06-20 | Millennium Pharmaceuticals, Inc. | 3700, a novel human protein kinase and uses therefor |
| US6261818B1 (en) * | 1998-12-11 | 2001-07-17 | Millennium Pharmaceuticals, Inc. | CARK protein and nucleic acid molecules and uses therefor |
| US6660490B2 (en) * | 1998-12-11 | 2003-12-09 | Millennnium Pharmaceuticals, Inc. | CARK protein and nucleic acid molecules and uses therefor |
| US6514719B1 (en) | 1999-05-28 | 2003-02-04 | Immunex Corporation | Methods for identifying compounds that alter kinase activity |
| US7001752B1 (en) | 1999-05-28 | 2006-02-21 | Immunex Corporation | Murine and human kinases |
| US6656698B1 (en) * | 1999-06-30 | 2003-12-02 | Millennium Pharmaceuticals, Inc. | 12832, a novel human kinase-like molecule and uses thereof |
| US6716616B1 (en) | 1999-09-28 | 2004-04-06 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| EP1484408A1 (en) * | 1999-09-28 | 2004-12-08 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| WO2001023579A1 (en) * | 1999-09-28 | 2001-04-05 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| WO2001025433A2 (en) * | 1999-10-07 | 2001-04-12 | Genentech, Inc. | Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| US6428980B1 (en) * | 1999-11-16 | 2002-08-06 | Rigel Pharmaceuticals, Inc. | Nucleic acids encoding RIP3 associated cell cycle proteins |
| EP1240194A2 (en) * | 1999-11-24 | 2002-09-18 | Sugen, Inc. | Novel human protein kinases and protein kinase-like enzymes |
| AU2575601A (en) * | 1999-12-10 | 2001-06-18 | Incyte Genomics, Inc. | Extracellular matrix and cell adhesion molecules |
| GB9929542D0 (en) * | 1999-12-14 | 2000-02-09 | Glaxo Wellcome Kk | Ikk4 |
| EP1255818A2 (en) * | 2000-02-09 | 2002-11-13 | Millennium Pharmaceuticals, Inc. | Methods for using 20893, a human protein kinase |
| AU2001238488A1 (en) * | 2000-02-17 | 2001-08-27 | Incyte Genomics, Inc. | Human kinases |
| US20020192204A1 (en) * | 2000-08-21 | 2002-12-19 | Rosana Kapeller-Libermann | 15985, a novel human serine/threonine protein kinase family member and uses thereof |
| US6864078B2 (en) | 2000-02-29 | 2005-03-08 | Millennium Pharmaceuticals, Inc. | 14790, novel protein kinase molecule and uses therefor |
| US7198930B2 (en) | 2000-02-29 | 2007-04-03 | Millennium Pharmaceuticals, Inc. | Human protein kinase, phosphatase, and protease family members and uses thereof |
| EP1261721A1 (en) * | 2000-03-08 | 2002-12-04 | MERCK PATENT GmbH | Human extracellular signal regulated kinases |
| US6458561B1 (en) | 2000-03-13 | 2002-10-01 | Incyte Genomics, Inc. | Human NIM1 kinase |
| WO2001073050A2 (en) | 2000-03-24 | 2001-10-04 | Millennium Pharmaceuticals, Inc. | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| US20030198953A1 (en) * | 2000-03-30 | 2003-10-23 | Spytek Kimberly A. | Novel proteins and nucleic acids encoding same |
| AU2001253489A1 (en) * | 2000-04-13 | 2001-10-30 | Millennium Pharmaceuticals, Inc. | 14257,protein kinase molecules and uses therefor |
| EP1294896A2 (en) * | 2000-04-25 | 2003-03-26 | Millennium Pharmaceuticals, Inc. | 13295 novel protein kinase molecules and uses therefor |
| WO2001081557A2 (en) * | 2000-04-25 | 2001-11-01 | Lexicon Genetics Incorporated | Human kinase proteins and polynucleotides encoding the same |
| EP1278863A2 (en) * | 2000-05-12 | 2003-01-29 | MERCK PATENT GmbH | Human serine-threonine kinase-4 |
| US20030108933A1 (en) * | 2000-05-12 | 2003-06-12 | Burkhard Scharm | Novel serine-threonine kinase-3 |
| AU7634301A (en) * | 2000-05-26 | 2001-12-03 | Bayer Aktiengesellschaft | Regulation of human p78-like serine/threonine kinase |
| US6413756B2 (en) * | 2000-06-06 | 2002-07-02 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6416990B2 (en) | 2000-06-06 | 2002-07-09 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6323016B1 (en) | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| AU2001268525A1 (en) * | 2000-06-15 | 2001-12-24 | Incyte Genomics, Inc. | Human kinases |
| US20040072177A1 (en) * | 2000-07-05 | 2004-04-15 | Burkhard Scharm | Novel human serine-threonine kinase |
| WO2002010402A2 (en) * | 2000-07-28 | 2002-02-07 | Chiron Corporation | Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| EP1307546A2 (en) * | 2000-08-03 | 2003-05-07 | 1149336 Ontario Inc. | Ampk-related serine/threonine kinase, designated snark |
| US6759221B1 (en) | 2000-08-18 | 2004-07-06 | Millennium Pharmaceuticals, Inc. | 14189, a novel human kinase and uses thereof |
| US6455291B1 (en) * | 2000-08-24 | 2002-09-24 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6555352B2 (en) * | 2000-08-31 | 2003-04-29 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6372468B1 (en) | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US20040072184A1 (en) * | 2000-09-20 | 2004-04-15 | Thillainathan Yoganathan | Cancer associated protein kinases and their uses |
| AU2002213183A1 (en) * | 2000-10-12 | 2002-04-22 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
| WO2002033056A2 (en) * | 2000-10-16 | 2002-04-25 | Bayer Aktiengesellschaft | Regulation of human serine-threonine protein kinase |
| AU2002214021A1 (en) * | 2000-10-16 | 2002-04-29 | Bayer Aktiengesellschaft | Regulation of human serine-threonine protein kinase |
| ATE479771T1 (de) * | 2000-11-09 | 2010-09-15 | Univ Virginia | Menschliche hodenspezifische serin/threonin- kinase |
| EP1443117B1 (en) * | 2000-11-09 | 2010-08-11 | University Of Virginia Patent Foundation | Human testis specific serine/threonine kinase |
| AU2002239483A1 (en) * | 2000-12-08 | 2002-06-18 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| EP1676917A3 (en) * | 2000-12-12 | 2006-07-12 | Lexicon Genetics Incorporated | Novel human kinases and uses thereof |
| AU3264202A (en) | 2000-12-12 | 2002-06-24 | Lexicon Genetics Inc | Novel human kinases and polynucleotides encoding the same |
| US6410294B1 (en) * | 2000-12-13 | 2002-06-25 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| AU2002211305A1 (en) * | 2000-12-14 | 2002-06-24 | Pe Corporation (Ny) | Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| US7119185B2 (en) * | 2000-12-21 | 2006-10-10 | Trustees Of The University Of Pennsylvania | Hormonally up-regulated, neu-tumor-associated kinase |
| US7049118B2 (en) | 2001-01-03 | 2006-05-23 | Bayer Healthcare Ag | Regulation of human serine-threonine protein kinase |
| WO2002055681A2 (en) * | 2001-01-11 | 2002-07-18 | Bayer Ag | Regulation of human tau-tubulin kinase |
| DE10102797A1 (de) * | 2001-01-22 | 2003-05-08 | Deutsches Krebsforsch | HIPK-Kinasen und deren Verwendung zur Beeinflussung der Zellteilung und Zellproliferation |
| US6686176B2 (en) * | 2001-01-23 | 2004-02-03 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| EP1227156A3 (en) * | 2001-01-30 | 2004-01-02 | Aeomica, Inc. | A human protein kinase domain-containing protein |
| US6492154B2 (en) * | 2001-01-31 | 2002-12-10 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002070678A2 (en) * | 2001-02-05 | 2002-09-12 | Bayer Aktiengesellschaft | Regulation of human serine/threonine protein kinase |
| US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
| US20030036183A1 (en) * | 2001-05-10 | 2003-02-20 | Boylan John F. | Serine threonine kinase member, h2520-40 |
| WO2002099083A2 (en) | 2001-06-05 | 2002-12-12 | Exelixis, Inc. | Gfats as modifiers of the p53 pathway and methods of use |
| US20030059918A1 (en) * | 2001-06-07 | 2003-03-27 | Bayer Aktiengesellschaft | Regulation of human serine/threonine protein kinase |
| WO2002099094A2 (en) * | 2001-06-07 | 2002-12-12 | Bayer Aktiengesellschaft | Human serine/threonine protein kinase-like enzyme |
| WO2003008582A1 (en) * | 2001-07-19 | 2003-01-30 | The New Industry Research Organization | Novel human-origin protein binding to sphingosine kinase 1 and polynucleotide encoding the protein |
| JP2005508169A (ja) * | 2001-10-31 | 2005-03-31 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 20750を使用した細胞増殖障害の診断および処置のための方法および組成物 |
| WO2003046167A1 (en) * | 2001-11-27 | 2003-06-05 | Bayer Healthcare Ag | Regulation of human serine/threonine protein kinase |
| JP2005518198A (ja) * | 2001-12-28 | 2005-06-23 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | Pak5関連の組成物及び方法 |
| US20030228595A1 (en) * | 2002-03-05 | 2003-12-11 | Applera Corporation | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US7189551B2 (en) | 2002-03-20 | 2007-03-13 | Bioptik Technology, Inc. | Human RPS6KA6-related gene variant associated with lung cancers |
| EP1393742A1 (en) * | 2002-08-14 | 2004-03-03 | atugen AG | Use of protein kinase N beta |
| MXPA05001766A (es) | 2002-08-14 | 2005-08-19 | Atugen Ag | Uso de proteina quinasa n beta. |
| US20060094013A1 (en) * | 2002-08-21 | 2006-05-04 | Hiroshi Takemori | Salt-inducible kinases 2 and use thereof |
| EP1549749A4 (en) * | 2002-10-10 | 2007-08-22 | Wyeth Corp | COMPOSITIONS, ORGANISMS AND METHODS USING A NEW HUMAN KINASE |
| US7122361B2 (en) | 2002-10-10 | 2006-10-17 | Wyeth | Compositions employing a novel human kinase |
| CA2503491A1 (en) | 2002-10-24 | 2004-05-06 | Wyeth | Calcineurin-like human phosphoesterase |
| WO2004050831A2 (en) | 2002-11-27 | 2004-06-17 | Wyeth | Compositions, organisms and methodologies employing a novel human kinase |
| WO2004098539A2 (en) | 2003-04-30 | 2004-11-18 | Incyte Corporation | Kinases and phosphatases |
| GB0328928D0 (en) * | 2003-12-12 | 2004-01-14 | Cancer Rec Tech Ltd | Materials and methods relating to cell cycle control |
| BRPI0519468A2 (pt) | 2004-12-27 | 2009-01-27 | Silence Therapeutics Ag | complexos de lipÍdeos revestido e seu uso |
| BRPI0714875A2 (pt) | 2006-07-21 | 2013-05-28 | Silence Therapeutics Ag | meios para inibir a expressço da proteÍna cinase 3 |
| US8399637B2 (en) * | 2006-08-24 | 2013-03-19 | The Trustees Of The University Of Pennsylvania | Nucleic acids encoding proteins for modulating Na,K-ATPase |
| US20130040894A1 (en) * | 2009-10-06 | 2013-02-14 | Tallinn University Of Technology | Inhibition or activation of serine/threonine ulk3 kinase activity |
| WO2025006571A1 (en) * | 2023-06-26 | 2025-01-02 | University Of Kentucky Research Foundation | Targeted destruction of pask by peptide-based degron |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994005794A1 (en) * | 1992-08-31 | 1994-03-17 | Massachusetts Institute Of Technology | DNA ENCODING THE HEME-REGULATED EUKARYOTIC INITIATION FACTOR 2α KINASE |
| CO4600637A1 (es) * | 1996-03-15 | 1998-05-08 | Corixa Corp | Compuestos para inmunoterapia e inmunodiagnosis del cancer de prostata |
| ES2270463T3 (es) * | 1996-06-10 | 2007-04-01 | Immunex Corporation | Quinasa activada por il-1/tnf-alfa (itak), y metodos para su elaboracion y utilizacion. |
| US5863729A (en) * | 1996-07-09 | 1999-01-26 | Washington University | DNA sequences encoding human TcAK1 kinase |
| US5863780A (en) * | 1996-09-12 | 1999-01-26 | Incyte Pharmaceuticals, Inc. | Human Protein Kinases |
| JP2002512507A (ja) * | 1997-01-21 | 2002-04-23 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌蛋白およびそれらをコードするポリヌクレオチド |
| JP2001511015A (ja) * | 1997-02-07 | 2001-08-07 | メルク エンド カンパニー インコーポレーテッド | サイクリン依存性プロテインキナーゼ |
| US6479274B1 (en) * | 1997-02-13 | 2002-11-12 | Amrad Operations Pty., Ltd. | DNA molecules encoding human HELA2 or testisin serine proteinases |
| DE19708173A1 (de) * | 1997-02-28 | 1998-09-03 | Dade Behring Marburg Gmbh | Zellvolumenregulierte humane Kinase h-sgk |
| US5965420A (en) * | 1997-03-05 | 1999-10-12 | Smithkline Beecham Corporation | Human protein kinases hYAK3 |
| US5885803A (en) * | 1997-06-19 | 1999-03-23 | Incyte Pharmaceuticals, Inc. | Disease associated protein kinases |
| JP2001516009A (ja) * | 1997-07-17 | 2001-09-25 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ガン関連核酸及びポリペプチド |
| AU1991899A (en) * | 1997-12-19 | 1999-07-12 | Karolinska Innovations Ab | Molecules associated with the human fused gene |
| AU1691499A (en) * | 1997-12-26 | 1999-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel kinase |
| US6432668B1 (en) * | 1997-12-30 | 2002-08-13 | Chiron Corporation | Polynucleotides encoding human cyclin-dependent kinase (hPFTAIRE) |
| US5962232A (en) * | 1998-01-30 | 1999-10-05 | Incyte Pharmaceuticals, Inc. | Protein kinase molecules |
| EP1073756A4 (en) * | 1998-03-26 | 2003-01-22 | Gene Logic Inc | IDENTIFICATION OF A cDNA ASSOCIATED WITH HUMAN HEART ISCHEMISTRY |
| WO1999050395A1 (fr) * | 1998-03-27 | 1999-10-07 | Helix Research Institute | Serine-threonine proteine-kinase exprimee dans le rein |
| WO1999057144A2 (en) * | 1998-05-05 | 1999-11-11 | Incyte Pharmaceuticals, Inc. | Human transcriptional regulator molecules |
| JP2002514401A (ja) * | 1998-05-13 | 2002-05-21 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 細胞シグナルタンパク質 |
| EP1084245B1 (en) * | 1998-06-11 | 2006-03-29 | AstraZeneca AB | Human receptor tyrosine kinase |
| WO2000006728A2 (en) * | 1998-07-28 | 2000-02-10 | Incyte Pharmaceuticals, Inc. | Phosphorylation effectors |
| US6262228B1 (en) * | 1998-08-17 | 2001-07-17 | Tularik Inc. | IRAK3 polypeptides and methods |
| US6183962B1 (en) * | 1998-09-09 | 2001-02-06 | Millennium Pharmaceuticals, Inc. | Protein kinase molecules and uses therefor |
| US6013455A (en) * | 1998-10-15 | 2000-01-11 | Incyte Pharmaceuticals, Inc. | Protein kinase homologs |
| WO2000035946A1 (en) * | 1998-12-14 | 2000-06-22 | The University Of Dundee | Methods |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| AU3899600A (en) * | 1999-03-18 | 2000-10-04 | Incyte Pharmaceuticals, Inc. | Regulators of intracellular phosphorylation |
| JP2004507202A (ja) * | 1999-03-31 | 2004-03-11 | キュラジェン コーポレイション | ポリペプチドをコードするオープンリーディングフレームを含む核酸;「orfx」 |
-
2000
- 2000-05-26 AU AU51734/00A patent/AU5173400A/en not_active Abandoned
- 2000-05-26 WO PCT/US2000/014842 patent/WO2000073469A2/en not_active Ceased
- 2000-05-26 CA CA002383244A patent/CA2383244A1/en not_active Abandoned
- 2000-05-26 EP EP00936414A patent/EP1180151A2/en not_active Withdrawn
- 2000-05-26 JP JP2001500781A patent/JP2003501038A/ja not_active Withdrawn
-
2006
- 2006-03-17 US US11/377,316 patent/US20060234344A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008522596A (ja) * | 2004-12-10 | 2008-07-03 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 血清/糖質コルチコイド調節キナーゼの使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20060234344A1 (en) | 2006-10-19 |
| WO2000073469A3 (en) | 2001-11-29 |
| EP1180151A2 (en) | 2002-02-20 |
| CA2383244A1 (en) | 2000-12-07 |
| AU5173400A (en) | 2000-12-18 |
| WO2000073469A2 (en) | 2000-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1073723B1 (en) | Ste20-related protein kinases | |
| US20060234344A1 (en) | Protein kinases | |
| EP1051500B1 (en) | Diagnosis and treatment of aur1 and/or aur2 related disorders | |
| JP3944241B2 (ja) | Aur―1および/またはaur―2関連疾患の診断および処置 | |
| US20040197792A1 (en) | Novel Kinases | |
| JP2001523081A (ja) | プロビン チロシン キナーゼ(PYK2)、そのcDNAクローニングおよびその用途 | |
| CA2394803A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| JP2003507016A (ja) | 新規な蛋白質ホスファターゼおよびホスファターゼ関連疾患の診断および治療 | |
| US20060140954A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| JP2003517836A (ja) | 哺乳動物蛋白質ホスファターゼ | |
| US6670167B1 (en) | Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof | |
| AU9223198A (en) | Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods | |
| CA2331889A1 (en) | Nek-related and bub1-related protein kinases | |
| US6495353B1 (en) | Human orthologues of wart | |
| JP2002525035A (ja) | 新規なリボゾームs6プロテインキナーゼの同定および機能的なキャラクタライゼーション | |
| US20030211989A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| US20020090703A1 (en) | Mammalian protein phosphatases | |
| US7029912B1 (en) | Tyrosine kinase substrate(Tks) proteins | |
| US20050084877A1 (en) | Mammalian protein phosphatases | |
| US20040048310A1 (en) | Novel human protein kinases and protein kinase-like enzymes | |
| JP2003510010A (ja) | Pyk2結合蛋白質 | |
| US20060019294A1 (en) | Tyrosine kinase substrate (Tks) proteins | |
| EP1533378A2 (en) | Tyrosine kinase substrate protein Tks7 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070412 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070412 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20080526 |